These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37579812)

  • 1. Advanced glycation and glycoxidation end products in bone.
    Wang B; Vashishth D
    Bone; 2023 Nov; 176():116880. PubMed ID: 37579812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Techniques for advanced glycation end product measurements for diabetic bone disease: pitfalls and future directions.
    Sroga GE; Stephen SJ; Wang B; Vashishth D
    Curr Opin Endocrinol Diabetes Obes; 2022 Aug; 29(4):333-342. PubMed ID: 35777968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Glycation End Products, Diabetes, and Bone Strength.
    Yamamoto M; Sugimoto T
    Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of advanced glycation end products (AGEs) in osteoporosis in diabetes.
    Yamagishi S
    Curr Drug Targets; 2011 Dec; 12(14):2096-102. PubMed ID: 22023404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach.
    LLabre JE; Sroga GE; Tice MJL; Vashishth D
    Bone; 2022 Mar; 156():116302. PubMed ID: 34952229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of Bone Quality in a Transgenic Mouse Model of Alzheimer's Disease.
    LLabre JE; Gil C; Amatya N; Lagalwar S; Possidente B; Vashishth D
    J Bone Miner Res; 2022 Dec; 37(12):2548-2565. PubMed ID: 36250342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
    Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
    BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo glycation-interplay between oxidant and carbonyl stress in bone.
    Sroga GE; Vashishth D
    JBMR Plus; 2024 Nov; 8(11):ziae110. PubMed ID: 39386996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.
    Karim L; Bouxsein ML
    Bone; 2016 Jan; 82():21-7. PubMed ID: 26211993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary glycation compounds - implications for human health.
    Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A
    Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility.
    Willett TL; Voziyan P; Nyman JS
    Bone; 2022 Oct; 163():116485. PubMed ID: 35798196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength.
    Leanza G; Cannata F; Faraj M; Pedone C; Viola V; Tramontana F; Pellegrini N; Vadalà G; Piccoli A; Strollo R; Zalfa F; Beeve AT; Scheller EL; Tang SY; Civitelli R; Maccarrone M; Papalia R; Napoli N
    Elife; 2024 Apr; 12():. PubMed ID: 38598270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New biomarkers of Maillard reaction damage to proteins.
    Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
    Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of non-enzymatic glycation on cancellous bone fragility.
    Tang SY; Zeenath U; Vashishth D
    Bone; 2007 Apr; 40(4):1144-51. PubMed ID: 17257914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation on the effects of in vitro induced advanced glycation end-products on cortical bone fracture mechanics at fall-related loading rates.
    Britton M; Parle E; Vaughan TJ
    J Mech Behav Biomed Mater; 2023 Feb; 138():105619. PubMed ID: 36525877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A map of glycation and glycoxidation sites in collagen I of human cortical bone: Effects of sex and type 2 diabetes.
    Voziyan P; Brown KL; Uppuganti S; Leser M; Rose KL; Nyman JS
    Bone; 2024 Oct; 187():117209. PubMed ID: 39047900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A direct role of collagen glycation in bone fracture.
    Poundarik AA; Wu PC; Evis Z; Sroga GE; Ural A; Rubin M; Vashishth D
    J Mech Behav Biomed Mater; 2015 Dec; 52():120-130. PubMed ID: 26530231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products and bone - How do we measure them and how do they correlate with bone mineral density and fractures? A systematic review and evaluation of precision of measures.
    Brandt IAG; Jessen MH; Rimestad DE; Højgaard MKF; Vestergaard P
    Bone; 2022 Dec; 165():116569. PubMed ID: 36174927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Glycation End Products, Bone Health, and Diabetes Mellitus.
    Jiang J; Zhao C; Han T; Shan H; Cui G; Li S; Xie Z; Wang J
    Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):671-677. PubMed ID: 36257297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products mediate biomineralization disorder in diabetic bone disease.
    Gao Q; Jiang Y; Zhou D; Li G; Han Y; Yang J; Xu K; Jing Y; Bai L; Geng Z; Zhang H; Zhou G; Zhu M; Ji N; Han R; Zhang Y; Li Z; Wang C; Hu Y; Shen H; Wang G; Shi Z; Han Q; Chen X; Su J
    Cell Rep Med; 2024 Sep; 5(9):101694. PubMed ID: 39173634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.